Cytokine levels during pregnancy influence immunological profiles and neurobehavioral patterns of the offspring

Annals of the New York Academy of Sciences

Volumn 1107, Issue , 2007, Pages 118-128

  Ponzio, Nicholas M ^a   Servatius, Richard ^a,b   Beck, Kevin ^a,b   Marzouk, Atara ^a   Kreider, Tim ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Animal models; Autism; Behavioral abnormalities; Cytokine dysregulation; IL 2; TH1 TH2 balance

Indexed keywords

CYTOKINE; INTERLEUKIN 2;

AMNION FLUID; ANIMAL EXPERIMENT; ANIMAL TISSUE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; EYELID REFLEX; FEMALE; FETUS; FETUS DEVELOPMENT; IMMUNOLOGY; ISOTOPE LABELING; MOUSE; MOUSE STRAIN; NONHUMAN; PREGNANCY; PRENATAL PERIOD; PROGENY; STATISTICAL SIGNIFICANCE; SWISS JAMES LAMBERT MOUSE; T LYMPHOCYTE; TH1 CELL; ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CELL CULTURE; IMMUNITY; MALE; METABOLISM; NEUROPHYSIOLOGY; NEWBORN; PRENATAL EXPOSURE; SPLEEN;

ANIMALIA; MURINAE; MUS;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CELLS, CULTURED; CYTOKINES; FEMALE; IMMUNITY; MALE; MICE; NEUROPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SPLEEN;

EID: 34648832289     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1381.013     Document Type: Conference Paper

References (40)

1. HOLLANDER, E. et al. 1998. A dimensional approach to the autism spectrum. CNS Spectrums 3: 22-39.
2. LAINHART, J.E. & J. PIVEN. 1995. Diagnosis, treatment, and neurobiology of autism in children. Curr. Opin. Pediatrics 7: 392-400.
3. DUGGAN, P.J. et al. 2001. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 358: 1699-1700.
4. PLETNIKOV, M.V. et al. 1999. Developmental brain injury associated with abnormal play behavior in neonatally borna disease virus-infected Lewis rats: a model of autism. Behav. Brain Res. 100.
5. HORNIG, M. et al. 1999. An infection-based model of neurodevelopmental damage. Proc. Natl. Acad. Sci. 96: 12101-12107.
6. PLETNIKOW, M.V. et al. 2001. Rat model of autism spectrum disorders. Genetic background effects on Borna disease virus-induced development brain damage. Ann. N. Y. Acad. Sci. 939: 318-319.
7. PATTERSON, P. 2002. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr. Opin. Neurobiol. 12: 115-118.
8. SHI, L. et al. 2003. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 23: 297-302.
9. SHI, L., N. TU & P. PATTERSON. 2005. Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus. Int. J. Dev. Neurosci. 23: 299-305.
10. SINGH, V.K. et al. 1991. Changes of soluble interleukin-2, interleukin-2 receptor, T8 antigen, and interleukin-1 in the serum of autistic children. Clin. Immunol. Immunopathol. 61: 448-455.
11. SINGH, V.K. 1996. Plasma increase of interleukin-12 and interferon-gamma: pathological significance in autism. J. Neuroimmunol. 66: 143-145.
12. GUPTA, S. et al. 1998. Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J. Neuroimmunol. 85: 106-109.
13. CROONENBERGHS, J. et al. 2002. Activation of the inflammatory response system in autism. Neuropsychobiology 45: 1-6.
14. JYONOUCHI, H., S. SUN & H. LE. 2001. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J. Neuroimmunol. 120: 170-179.
15. VARGAS, D. et al. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57: 67-81.
16. WAGUESPACK, P., W. BANKS & A. KASTIN. 1994. Interleukin-2 does not cross the blood-brain barrier by a saturable transport system. Brain Res. Bull. 34: 103-109.
17. PLATA-SALAMAN, C. 1991. Immunoregulators in the nervous system. Neurosci. Biobehav. Rev. 15: 185-215.
18. LAPCHAK, P. 1992. A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport 3: 165-168.
19. ALONSO, R. et al. 1993. Interleukin-2 modulates evoked release of [3H] dopamin in rat cultured mesencephalic cells. J. Neurochem. 61: 1284-1290.
20. ZALCMAN, S. et al. 1994. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 643: 40-49.
21. ANISMAN, H., L. KOKKINIDIS & Z. MERALI. 1996. Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation. Brain Res. 731: 1-11.
22. PETITTO, J.M. et al. 1997. Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J. Neuroimmunol. 73: 183-190.
23. NISTICO, G. & G. DE SARRO. 1991. Behavioral and electrocortical spectrum power effects after microinfusion of lymphokines in several areas of the rat brain. Ann. N. Y. Acad. Sci. 621: 119-134.
24. ZALCMAN, S. et al. 1998. Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res. 811: 111-121.
25. ZALCMAN, S.S. 2001. Interleukin-2 potentiates novelty- and GBR 12909-induced exploratory activity. Brain Res. 889: 1-9.
26. ZALCMAN, S. 2002. Interleukin-2-induced increases in climbing behavior: inhibition by dopamine D-1 and D-2 receptor antagonists. Brain Res. 944: 157-164.
27. LIN, T.-Z. et al. 1992. IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouse. Clin. Immunol. Immunopathol. 65: 10-22.
28. ERIANNE, G., J. WAJCHMAN & N.M. PONZIO. 2000. B lymphoma cells of C57L mice; the role of natural killer cells and T helper cells in lymphoma development and growth. Leukemia Res. 24: 705-718.
29. WAJCHMAN, J. et al. 2002. Interleukin-12-induced cytotoxicity against syngeneic B cell lymphomas of SJL/J mice. Leukemia Res. 26: 577-590.
30. SIMMONS, W. et al. 2005. Tim-3+ T-bet+ tumor specific TH1 cells co-localize with and inhibit development and growth of B Cell lymphomas. J. Immunol. 174: 1405-1415.
31. PONZIO, N.M. et al. 2006. CpG oligodeoxynucleotide- induced immunity prevents growth of germinal center-derived B lymphoma cells. Int. Immunopharmacol. 6: 2057-2068.
32. ZALCMAN, S. et al. 2004. Maternal exposure to interleukin-2 induces long-lasting increases in behavioral and neuronal responses to novelty and psychostimulant challenge in offspring. Society for Neuroscience. 34th Annual Meeting. Program No. 806.16.
33. SERVATIUS, R. 2000. Eyeblink conditioning in freely moving rat: square-wave stimulation as the unconditioned stimulus. J. Neurosci. Methods 102: 35-42.
34. SEARS, L., P. FINN & J. STEINMETZ. 1994. Abnormal classical eye-blink conditioning in autism. J. Autism Dev. Disord. 24: 737-751.
35. WEGMAN, T.G. et al. 1993. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 14: 353-356.
36. DEALTRY, G.B., M.K. O'FARRELL & N. FERNANDEZ. 2000. The Th2 cytokine environment of the placenta. Int. Arch. Allergy Immunol. 123: 107-119.
37. SZEKERES-BARTHO, J. 2002. Immunological relationship between the mother and the fetus. Int. Rev. Immunol. 21: 471-495.
38. ARAUJO, D.M. et al. 1989. Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res. 498: 257-266.
39. ZALCMAN, S.S. et al. 2004. Maternal exposure to interleukin-2 induces long-lasting increases in novelty- and psychostimulant-induced stereotypic behavior and neuronal activation in male offspring. Integrating the Clinical and Basic Sciences of Autism: A Developmental Biology Workshop, National Alliance for Autism Research.
40. LOTZE, M.T. et al. 1985. In vivo administration of purified human interleukin 2. II. Half life, immunological effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. J. Immunol. 135: 2865-2875.